132 related articles for article (PubMed ID: 17949249)
1. Renal activity of Akt kinase in experimental Type 1 diabetes.
Ždychová J; Veselá J; Kazdová L; Komers R
Physiol Res; 2008; 57(5):709-716. PubMed ID: 17949249
[TBL] [Abstract][Full Text] [Related]
2. Liraglutide protects from renal damage via Akt-mTOR pathway in rats with diabetic kidney disease.
Liao TT; Zhao LB; Liu H; He RL; Wang YQ; Li J
Eur Rev Med Pharmacol Sci; 2019 Aug; 23(3 Suppl):117-125. PubMed ID: 31389583
[TBL] [Abstract][Full Text] [Related]
3. Ethanolic Ginkgo biloba leaf extract prevents renal fibrosis through Akt/mTOR signaling in diabetic nephropathy.
Lu Q; Zuo WZ; Ji XJ; Zhou YX; Liu YQ; Yao XQ; Zhou XY; Liu YW; Zhang F; Yin XX
Phytomedicine; 2015 Nov; 22(12):1071-8. PubMed ID: 26547529
[TBL] [Abstract][Full Text] [Related]
4. Renal p38 MAP kinase activity in experimental diabetes.
Komers R; Lindsley JN; Oyama TT; Cohen DM; Anderson S
Lab Invest; 2007 Jun; 87(6):548-58. PubMed ID: 17401436
[TBL] [Abstract][Full Text] [Related]
5. Renal activity of Akt kinase in obese Zucker rats.
Zdychová J; Kazdová L; Pelikanová T; Lindsley JN; Anderson S; Komers R
Exp Biol Med (Maywood); 2008 Oct; 233(10):1231-41. PubMed ID: 18641049
[TBL] [Abstract][Full Text] [Related]
6. Activation of the PDK-1/Akt/eNOS pathway involved in aortic endothelial function differs between hyperinsulinemic and insulin-deficient diabetic rats.
Kobayashi T; Taguchi K; Nemoto S; Nogami T; Matsumoto T; Kamata K
Am J Physiol Heart Circ Physiol; 2009 Nov; 297(5):H1767-75. PubMed ID: 19717727
[TBL] [Abstract][Full Text] [Related]
7. Diabetes causes bone marrow endothelial barrier dysfunction by activation of the RhoA-Rho-associated kinase signaling pathway.
Mangialardi G; Katare R; Oikawa A; Meloni M; Reni C; Emanueli C; Madeddu P
Arterioscler Thromb Vasc Biol; 2013 Mar; 33(3):555-64. PubMed ID: 23307872
[TBL] [Abstract][Full Text] [Related]
8. Thyroid hormone improves the mechanical performance of the post-infarcted diabetic myocardium: a response associated with up-regulation of Akt/mTOR and AMPK activation.
Mourouzis I; Giagourta I; Galanopoulos G; Mantzouratou P; Kostakou E; Kokkinos AD; Tentolouris N; Pantos C
Metabolism; 2013 Oct; 62(10):1387-93. PubMed ID: 23773982
[TBL] [Abstract][Full Text] [Related]
9. The essential role of endothelial nitric oxide synthase activation in insulin-mediated neuroprotection against ischemic stroke in diabetes.
Huang SS; Lu YJ; Huang JP; Wu YT; Day YJ; Hung LM
J Vasc Surg; 2014 Feb; 59(2):483-91. PubMed ID: 23663869
[TBL] [Abstract][Full Text] [Related]
10. [Carnosine protects against diabetic nephropathy in rats by activating the AKT/mTOR pathway and restoring autophagy in the renal tissue].
Ren Y; Lu J; Yu L; Li Z; Wang G; Yang J
Nan Fang Yi Ke Da Xue Xue Bao; 2023 Nov; 43(11):1965-1970. PubMed ID: 38081616
[TBL] [Abstract][Full Text] [Related]
11. Regulation of elongation phase of mRNA translation in diabetic nephropathy: amelioration by rapamycin.
Sataranatarajan K; Mariappan MM; Lee MJ; Feliers D; Choudhury GG; Barnes JL; Kasinath BS
Am J Pathol; 2007 Dec; 171(6):1733-42. PubMed ID: 17991718
[TBL] [Abstract][Full Text] [Related]
12. Chronic tempol treatment attenuates the renal hemodynamic effects induced by a heme oxygenase inhibitor in streptozotocin diabetic rats.
Rodriguez F; Lopez B; Perez C; Fenoy FJ; Hernandez I; Stec DE; Li Volti G; Salom MG
Am J Physiol Regul Integr Comp Physiol; 2011 Nov; 301(5):R1540-8. PubMed ID: 21849637
[TBL] [Abstract][Full Text] [Related]
13. Increased renal Akt/mTOR and MAPK signaling in type I diabetes in the absence of IGF type 1 receptor activation.
Landau D; Eshet R; Troib A; Gurman Y; Chen Y; Rabkin R; Segev Y
Endocrine; 2009 Aug; 36(1):126-34. PubMed ID: 19387875
[TBL] [Abstract][Full Text] [Related]
14. Losartan affects glomerular AKT and mTOR phosphorylation in an experimental model of type 1 diabetic nephropathy.
Mavroeidi V; Petrakis I; Stylianou K; Katsarou T; Giannakakis K; Perakis K; Vardaki E; Stratigis S; Ganotakis E; Papavasiliou S; Daphnis E
J Histochem Cytochem; 2013 Jun; 61(6):433-43. PubMed ID: 23456824
[TBL] [Abstract][Full Text] [Related]
15. MDG-1, a polysaccharide from Ophiopogon japonicus exerts hypoglycemic effects through the PI3K/Akt pathway in a diabetic KKAy mouse model.
Wang LY; Wang Y; Xu DS; Ruan KF; Feng Y; Wang S
J Ethnopharmacol; 2012 Aug; 143(1):347-54. PubMed ID: 22776833
[TBL] [Abstract][Full Text] [Related]
16. The effect of Liuwei Dihuang decoction on PI3K/Akt signaling pathway in liver of type 2 diabetes mellitus (T2DM) rats with insulin resistance.
Dai B; Wu Q; Zeng C; Zhang J; Cao L; Xiao Z; Yang M
J Ethnopharmacol; 2016 Nov; 192():382-389. PubMed ID: 27401286
[TBL] [Abstract][Full Text] [Related]
17. PI3K/AKT/mTOR pathway plays a major pathogenetic role in glycogen accumulation and tumor development in renal distal tubules of rats and men.
Ribback S; Cigliano A; Kroeger N; Pilo MG; Terracciano L; Burchardt M; Bannasch P; Calvisi DF; Dombrowski F
Oncotarget; 2015 May; 6(15):13036-48. PubMed ID: 25948777
[TBL] [Abstract][Full Text] [Related]
18. Tangganjian decoction ameliorates type 2 diabetes mellitus and nonalcoholic fatty liver disease in rats by activating the IRS/PI3K/AKT signaling pathway.
Fan Y; He Z; Wang W; Li J; Hu A; Li L; Yan L; Li Z; Yin Q
Biomed Pharmacother; 2018 Oct; 106():733-737. PubMed ID: 29990865
[TBL] [Abstract][Full Text] [Related]
19. EGFR-PLCgamma1 signaling mediates high glucose-induced PKCbeta1-Akt activation and collagen I upregulation in mesangial cells.
Wu D; Peng F; Zhang B; Ingram AJ; Kelly DJ; Gilbert RE; Gao B; Kumar S; Krepinsky JC
Am J Physiol Renal Physiol; 2009 Sep; 297(3):F822-34. PubMed ID: 19605547
[TBL] [Abstract][Full Text] [Related]
20. Effects of streptozotocin-induced type 1 maternal diabetes on PI3K/AKT signaling pathway in the hippocampus of rat neonates.
Hami J; Kerachian MA; Karimi R; Haghir H; Sadr-Nabavi A
J Recept Signal Transduct Res; 2016; 36(3):254-60. PubMed ID: 26479041
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
